KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

VivoSim Labs (VIVS) Liabilities and Shareholders Equity (2016 - 2025)

VivoSim Labs (VIVS) has 15 years of Liabilities and Shareholders Equity data on record, last reported at $7.0 million in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 81.06% year-over-year to $7.0 million; the TTM value through Dec 2025 reached $43.3 million, up 63.81%, while the annual FY2025 figure was $14.6 million, 130.74% up from the prior year.
  • Liabilities and Shareholders Equity reached $7.0 million in Q4 2025 per VIVS's latest filing, down from $9.7 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $39.9 million in Q1 2021 and bottomed at $3.8 million in Q4 2024.
  • Average Liabilities and Shareholders Equity over 5 years is $19.5 million, with a median of $14.7 million recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: crashed 68.74% in 2024, then surged 130.74% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $35.1 million in 2021, then dropped by 28.54% to $25.1 million in 2022, then tumbled by 64.59% to $8.9 million in 2023, then crashed by 56.72% to $3.8 million in 2024, then surged by 81.06% to $7.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $7.0 million in Q4 2025, $9.7 million in Q3 2025, and $12.0 million in Q2 2025.